Carl Hull
First SEC filing: Nov. 30, 2020 · Latest: Nov. 30, 2020
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 11, 2024 | MRVI | P | 175,000 | $5.64 | $987,000 | 175,000 Indirect | · | Acquired | 51.1% (price as of 2026-10-05) |
| March 15, 2024 | MRVI | F | 17,560 | $7.70 | $135,212 | 267,072 Direct | -6.17% | Disposed | 10.6% (price as of 2026-10-05) |
| Feb. 15, 2024 | MRVI | F | 10,729 | $5.48 | $58,795 | 284,632 Direct | -3.63% | Disposed | 55.5% (price as of 2026-10-05) |
| Jan. 16, 2024 | MRVI | A | 75,842 | · | · | 295,361 Direct | +34.55% | Acquired | (price as of 2026-10-05) |
| March 15, 2023 | MRVI | A | 147,638 | · | · | 219,519 Direct | +205.39% | Acquired | (price as of 2026-10-05) |
| March 15, 2023 | MRVI | A | 270,109 | · | · | 270,109 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 15, 2023 | MRVI | F | 9,719 | $15.23 | $148,020 | 71,881 Direct | -11.91% | Disposed | -44.1% (price as of 2026-10-05) |
| Jan. 25, 2022 | MRVI | A | 151,200 | · | · | 151,200 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 25, 2022 | MRVI | A | 81,600 | · | · | 81,600 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 25, 2020 | MRVI | P | 35,000 | $26.94 | $942,900 | 35,000 Indirect | · | Acquired | -68.4% (price as of 2026-10-05) |
| Nov. 19, 2020 | MRVI | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 15, 2023 | MRVI | Employee Stock Options (Right to Buy) | Class A Common Stock | $15.52 | March 15, 2033 | 270,109 | Acquired |
| Jan. 25, 2022 | MRVI | Employee Stock Options (Right to Buy) | Class A Common Stock | $26.32 | Jan. 25, 2032 | 151,200 | Acquired |
| Nov. 19, 2020 | MRVI | Employee Stock Options (Right to Buy) | Class A Common Stock | $27.00 | Nov. 19, 2030 | 60,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $500,000 | · | · | · | $750,000 | · | · | $2,124,160 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.